Trials / Completed
CompletedNCT01736787
Efficacy and Safety of Cauliflower Mushroom Extract on Promotion of Immunity
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Chonbuk National University Hospital · Academic / Other
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Cauliflower Mushroom extract on promotion of immunity. The investigators measured promotion of immunity parameters , including Cytotoxicity, Cytokine (IL-4, IL-10, IFN- γ, TNF-α), and CBC (WBC, RBC, Hb, Hct, MCV, MCH, MCHC, PLT), and monitored their blood pressure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Cauliflower Mushroom extract | Cauliflower Mushroom extract (1g/day) |
| DIETARY_SUPPLEMENT | Placebo | Placebo (1g/day) |
Timeline
- Start date
- 2012-09-17
- Primary completion
- 2013-01-18
- Completion
- 2013-01-18
- First posted
- 2012-11-29
- Last updated
- 2019-09-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01736787. Inclusion in this directory is not an endorsement.